Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids

Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advance...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2015-05, Vol.70 (5), p.468-472
Hauptverfasser: Brokx, Hes A P, Paul, Marinus A, Postmus, Pieter E, Sutedja, Thomas G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 472
container_issue 5
container_start_page 468
container_title Thorax
container_volume 70
creator Brokx, Hes A P
Paul, Marinus A
Postmus, Pieter E
Sutedja, Thomas G
description Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.
doi_str_mv 10.1136/thoraxjnl-2014-206753
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673371730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1673371730</sourcerecordid><originalsourceid>FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</originalsourceid><addsrcrecordid>eNqNkU9P3DAQxS1UxC60H4HKUi9cXOz4b44VagFppV7gbBzHYb1K7NR2RPn2GO2yh556mRmNfu9pNA-AS4K_E0LFddnGZP7uwogaTFgtQnJ6AtaECYVo04pPYI0xw0hQKVbgPOcdxlgRIs_AquFSSq7EGjxtYnhGxaUJDnEc4wtaZmiGuoCDT7mg0QcHuxSD3cZs4-wtLFuXzPwKfYCzKd6FkuGLL9sD5s0IrUnWh-j7_BmcDmbM7suhX4DHXz8fbu7Q5vft_c2PDepYwwviVFBmOtK2VgnVsjpxqYauHzhplVLONM5YyvhgpWFN31jOSGVV39FOME4vwNXed07xz-Jy0ZPP1o2jCS4uWRMhKZVEUlzRb_-gu7ikUK_TRCqiGiGFqBTfUzbFnJMb9Jz8ZNKrJli_R6CPEej3CPQ-gqr7enBfusn1R9XHzyuA90A37f7T8w2XC5UL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781826766</pqid></control><display><type>article</type><title>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Alma/SFX Local Collection</source><creator>Brokx, Hes A P ; Paul, Marinus A ; Postmus, Pieter E ; Sutedja, Thomas G</creator><creatorcontrib>Brokx, Hes A P ; Paul, Marinus A ; Postmus, Pieter E ; Sutedja, Thomas G</creatorcontrib><description>Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2014-206753</identifier><identifier>PMID: 25777586</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Adolescent ; Adult ; Aged ; Bronchial Neoplasms - mortality ; Bronchial Neoplasms - pathology ; Bronchial Neoplasms - surgery ; Bronchoscopy ; Carcinoid Tumor - mortality ; Carcinoid Tumor - pathology ; Carcinoid Tumor - surgery ; Classification ; Clinical Protocols ; Female ; Follow-Up Studies ; Histology ; Humans ; Lymphatic system ; Male ; Middle Aged ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Neoplasm, Residual ; Patients ; Pneumonectomy ; Surgery ; Surveillance ; Treatment Outcome ; Tumors ; Young Adult</subject><ispartof>Thorax, 2015-05, Vol.70 (5), p.468-472</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</citedby><cites>FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://thorax.bmj.com/content/70/5/468.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://thorax.bmj.com/content/70/5/468.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3194,23569,27922,27923,77370,77401</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25777586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brokx, Hes A P</creatorcontrib><creatorcontrib>Paul, Marinus A</creatorcontrib><creatorcontrib>Postmus, Pieter E</creatorcontrib><creatorcontrib>Sutedja, Thomas G</creatorcontrib><title>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Bronchial Neoplasms - mortality</subject><subject>Bronchial Neoplasms - pathology</subject><subject>Bronchial Neoplasms - surgery</subject><subject>Bronchoscopy</subject><subject>Carcinoid Tumor - mortality</subject><subject>Carcinoid Tumor - pathology</subject><subject>Carcinoid Tumor - surgery</subject><subject>Classification</subject><subject>Clinical Protocols</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Histology</subject><subject>Humans</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm, Residual</subject><subject>Patients</subject><subject>Pneumonectomy</subject><subject>Surgery</subject><subject>Surveillance</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkU9P3DAQxS1UxC60H4HKUi9cXOz4b44VagFppV7gbBzHYb1K7NR2RPn2GO2yh556mRmNfu9pNA-AS4K_E0LFddnGZP7uwogaTFgtQnJ6AtaECYVo04pPYI0xw0hQKVbgPOcdxlgRIs_AquFSSq7EGjxtYnhGxaUJDnEc4wtaZmiGuoCDT7mg0QcHuxSD3cZs4-wtLFuXzPwKfYCzKd6FkuGLL9sD5s0IrUnWh-j7_BmcDmbM7suhX4DHXz8fbu7Q5vft_c2PDepYwwviVFBmOtK2VgnVsjpxqYauHzhplVLONM5YyvhgpWFN31jOSGVV39FOME4vwNXed07xz-Jy0ZPP1o2jCS4uWRMhKZVEUlzRb_-gu7ikUK_TRCqiGiGFqBTfUzbFnJMb9Jz8ZNKrJli_R6CPEej3CPQ-gqr7enBfusn1R9XHzyuA90A37f7T8w2XC5UL</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Brokx, Hes A P</creator><creator>Paul, Marinus A</creator><creator>Postmus, Pieter E</creator><creator>Sutedja, Thomas G</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201505</creationdate><title>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</title><author>Brokx, Hes A P ; Paul, Marinus A ; Postmus, Pieter E ; Sutedja, Thomas G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b425t-53634ab199c86894b19578fbdf519888ea2eac345fc7a42d2c5419c88db3b6453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Bronchial Neoplasms - mortality</topic><topic>Bronchial Neoplasms - pathology</topic><topic>Bronchial Neoplasms - surgery</topic><topic>Bronchoscopy</topic><topic>Carcinoid Tumor - mortality</topic><topic>Carcinoid Tumor - pathology</topic><topic>Carcinoid Tumor - surgery</topic><topic>Classification</topic><topic>Clinical Protocols</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Histology</topic><topic>Humans</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm, Residual</topic><topic>Patients</topic><topic>Pneumonectomy</topic><topic>Surgery</topic><topic>Surveillance</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brokx, Hes A P</creatorcontrib><creatorcontrib>Paul, Marinus A</creatorcontrib><creatorcontrib>Postmus, Pieter E</creatorcontrib><creatorcontrib>Sutedja, Thomas G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brokx, Hes A P</au><au>Paul, Marinus A</au><au>Postmus, Pieter E</au><au>Sutedja, Thomas G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2015-05</date><risdate>2015</risdate><volume>70</volume><issue>5</issue><spage>468</spage><epage>472</epage><pages>468-472</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>Background Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach. Methods In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT. Results Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16–77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC). Conclusions IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>25777586</pmid><doi>10.1136/thoraxjnl-2014-206753</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2015-05, Vol.70 (5), p.468-472
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_miscellaneous_1673371730
source MEDLINE; BMJ Journals - NESLi2; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Bronchial Neoplasms - mortality
Bronchial Neoplasms - pathology
Bronchial Neoplasms - surgery
Bronchoscopy
Carcinoid Tumor - mortality
Carcinoid Tumor - pathology
Carcinoid Tumor - surgery
Classification
Clinical Protocols
Female
Follow-Up Studies
Histology
Humans
Lymphatic system
Male
Middle Aged
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - surgery
Neoplasm, Residual
Patients
Pneumonectomy
Surgery
Surveillance
Treatment Outcome
Tumors
Young Adult
title Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow-up%20after%20first-line%20bronchoscopic%20therapy%20in%20patients%20with%20bronchial%20carcinoids&rft.jtitle=Thorax&rft.au=Brokx,%20Hes%20A%20P&rft.date=2015-05&rft.volume=70&rft.issue=5&rft.spage=468&rft.epage=472&rft.pages=468-472&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thoraxjnl-2014-206753&rft_dat=%3Cproquest_cross%3E1673371730%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781826766&rft_id=info:pmid/25777586&rfr_iscdi=true